Karin Helena Johansson Wingstrand

Director/Board Member chez XBRANE BIOPHARMA AB

Profil

Karin Helena Johansson Wingstrand is currently the Director at T-Bolaget AB since 2001, Independent Director at Xbrane Biopharma AB since 2015, Director at Sahlgrenska Forskningsstiftelsen, Director at Winkon Holding AB, Independent Director at Integrum AB since 2019, Director at Histolab Products AB, and Partner at Aqilion AB since 2014.
Previously, she was the Director at Adenovir Pharma AB from 2015 to 2018, Director at Xintela AB from 2014 to 2022, Director at Swecure AB from 2014 to 2018, and Global Head-Clinical Development at AstraZeneca AB from 1999 to 2008.
She holds a graduate degree from the University of Uppsala.

Postes actifs de Karin Helena Johansson Wingstrand

Sociétés	Poste	Début
XBRANE BIOPHARMA AB	Director/Board Member	01/01/2015
INTEGRUM AB	Director/Board Member	01/01/2019
T-Bolaget AB	Director/Board Member	01/01/2001
Sahlgrenska Forskningsstiftelsen	Director/Board Member	-
Winkon Holding AB	Director/Board Member	-
Aqilion AB	Private Equity Investor	13/02/2014
Histolab Products AB	Director/Board Member	-

Anciens postes connus de Karin Helena Johansson Wingstrand

Sociétés	Poste	Fin
XINTELA AB	Director/Board Member	01/01/2022
Swecure AB	Director/Board Member	01/01/2018
░░░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░	░░░░░ ░░░░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░	░░░░░░░░	-

Formation de Karin Helena Johansson Wingstrand

University of Uppsala

Graduate Degree